Stack AI
AI agents that interact and answer questions with users and complete tasks using your data and APIs. AI that can answer questions, summarize and extract insights from any long document. Transfer styles and formats, as well as tags and summaries between documents and data sources. Stack AI is used by developer teams to automate customer service, process documents, qualify leads, and search libraries of data. With a single button, you can try multiple LLM architectures and prompts. Collect data, run fine-tuning tasks and build the optimal LLM to fit your product. We host your workflows in APIs, so that your users have access to AI instantly. Compare the fine-tuning services of different LLM providers.
Learn more
AWS Step Functions
AWS Step Functions serves as a serverless orchestrator, simplifying the process of arranging AWS Lambda functions alongside various AWS services to develop essential business applications. It features a visual interface that allows users to design and execute a series of event-driven workflows with checkpoints, ensuring that the application state is preserved throughout. The subsequent step in the workflow utilizes the output from the previous one, creating a seamless flow dictated by the specified business logic. As each component of your application is executed in the designated order, the orchestration of distinct serverless applications can present challenges, especially with tasks like managing retries and troubleshooting issues. The increasing complexity of distributed applications demands effective management strategies, which can be daunting. However, Step Functions alleviates much of this operational strain through integrated controls that handle sequencing, error management, retry mechanisms, and state maintenance. This functionality allows teams to focus more on innovation rather than the intricacies of application management. Ultimately, AWS Step Functions empowers users to translate business needs into technical solutions rapidly by providing intuitive visual workflows for streamlined development.
Learn more
BIOiSIM
BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.
Learn more
BioNeMo
BioNeMo is a cloud service and framework for drug discovery that leverages AI, built on NVIDIA NeMo Megatron, which enables the training and deployment of large-scale biomolecular transformer models. This service features pre-trained large language models (LLMs) and offers comprehensive support for standard file formats related to proteins, DNA, RNA, and chemistry, including data loaders for SMILES molecular structures and FASTA sequences for amino acids and nucleotides. Additionally, users can download the BioNeMo framework for use on their own systems. Among the tools provided are ESM-1 and ProtT5, both transformer-based protein language models that facilitate the generation of learned embeddings for predicting protein structures and properties. Furthermore, the BioNeMo service will include OpenFold, an advanced deep learning model designed for predicting the 3D structures of novel protein sequences, enhancing its utility for researchers in the field. This comprehensive offering positions BioNeMo as a pivotal resource in modern drug discovery efforts.
Learn more